Authors:
- Focuses on industrial standardization of pharmaceuticals which makes modern medicines spread around the world as well as quality problems
- Discusses the IMPACT led by WHO which has misled the discussions on the nature of the problem worldwide
- Examines the divided markets corresponding to the wealth gap
- Proposes the poor quality pharmaceuticals are accordingly caused by the failures of government and markets
Part of the book series: Trust (TRUST, volume 5)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (11 chapters)
-
Front Matter
-
Pharmaceuticals in Globalization
-
Front Matter
-
About this book
Authors and Affiliations
-
Department of Reference Standards, Pharmaceutical and Device Regulatory Science Society of Japan, Osaka, Japan
Satoru Kimura
-
School of Nursing and Rehabilitation, Konan Women's University, Kobe, Japan
Yasuhide Nakamura
About the authors
After graduating from the Biophysical Engineering, School of Engineering Science, Osaka University in 1972, he started his career in the food industry and then, was engaged in duties related to clinical studies and drug safety/pharmacovigilance in American and European affiliated pharmaceutical companies.
In March 2017, he completed the Doctor's Program in the International Cooperation Studies, Graduate School of Human Sciences, Osaka University. His Ph.D. thesis investigated, ‘Conflicts of Interest around the Quality of Medicines in the International Community.’ Since May 2018, he has been a board member at the WHO Association of Japan.
Yasuhide NAKAMURA is a Professor of School of Nursing and Rehabilitation, Konan Women's University and Professor Emeritus of Osaka University.
After graduating from The University of Tokyo, and working as a pediatrician at Tokyo Metropolitan Hospital, he started global health to encourage maternal and child health in Indonesia as a Japan International Cooperation Agency (JICA) expert (1986-88) and to promote the refugee health program in UNHCR Pakistan Office (1990-91). Dr. NAMAKURA was a Takemi Fellow (1996-97) in Harvard School of Public Health for international health and worked in the Graduate School of Human Sciences, Osaka University (2000-2017). He is widely interested in conducting research through an interdisciplinary approach in the spirit of the fieldworker; international Maternal and Child Health (MCH) Handbook Programs; humanitarian relief for refugees and victims by natural disasters, and health care systems in Japan.
Dr. Nakamura is president of the Japan Association for International Health (JAIH), the representative of International Society of Volunteer Studies and president of the WHO Association of Japan. He got the 43th Medical Achievement Award (Iryo Kourou Sho) in 2015.
Bibliographic Information
Book Title: Poor Quality Pharmaceuticals in Global Public Health
Authors: Satoru Kimura, Yasuhide Nakamura
Series Title: Trust
DOI: https://doi.org/10.1007/978-981-15-2089-1
Publisher: Springer Singapore
eBook Packages: Social Sciences, Social Sciences (R0)
Copyright Information: Springer Nature Singapore Pte Ltd. 2020
Hardcover ISBN: 978-981-15-2088-4Published: 17 January 2020
Softcover ISBN: 978-981-15-2091-4Published: 17 January 2021
eBook ISBN: 978-981-15-2089-1Published: 16 January 2020
Series ISSN: 2509-7679
Series E-ISSN: 2509-7903
Edition Number: 1
Number of Pages: XXIII, 191
Number of Illustrations: 7 b/w illustrations, 15 illustrations in colour
Topics: Public Health, Medical Sociology, Corporate Social Responsibility, Development and Health